Last reviewed · How we verify
Oral tablet and transdermal patch
Oral tablet and transdermal patch is a Small molecule drug developed by B.P. Koirala Institute of Health Sciences. It is currently FDA-approved.
Oral tablets and transdermal patches are used to treat various conditions, including pain, postoperative pain, nausea, vomiting, and transgenderism. The effectiveness of these two delivery methods has been compared in clinical trials, such as one comparing transdermal diclofenac to an oral combination of paracetamol and ibuprofen for postoperative pain management.
At a glance
| Generic name | Oral tablet and transdermal patch |
|---|---|
| Sponsor | B.P. Koirala Institute of Health Sciences |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Varenicline and Combined NRT for Smoking Cessation (PHASE4)
- Estrogen Variability and Irritability During the Menopause Transition (PHASE4)
- Valproate for the Treatment of Residual Amblyopia (PHASE1, PHASE2)
- Role of Menopause in Thermoregulation (PHASE4)
- A COMPARISON OF TRANSDERMAL DICLOFENAC AND ORAL COMBINATION OF PARACETAMOL AND IBUPROFEN IN POSTOPERATIVE PAIN MANAGEMENT FOLLOWING SURGICAL EXTRACTION OF MANDIBULAR THIRD MOLAR- A RANDOMISD CONTROLLED TRIALS. (PHASE4)
- Coagulation and Fibrinolysis of Estradiol in Transwomen (EARLY_PHASE1)
- PRE-GAiN Bone Health Pilot Study (PHASE1)
- Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Oral tablet and transdermal patch CI brief — competitive landscape report
- Oral tablet and transdermal patch updates RSS · CI watch RSS
- B.P. Koirala Institute of Health Sciences portfolio CI
Frequently asked questions about Oral tablet and transdermal patch
What is Oral tablet and transdermal patch?
Who makes Oral tablet and transdermal patch?
What development phase is Oral tablet and transdermal patch in?
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing